Contacts
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
Pharmacovigilance
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
Pharmacovigilance group
of the Medical Department.
UNIFUZOL® is used in adult patients with obliterating atherosclerosis of the lower limb arteries aged 18 years and older. The primary therapeutic benefit of Unifuzol® is achieved by effect on peripheral vascular tone.
The medication improves microcirculation in impaired blood flow areas by activating nitrogen monoxide production and stimulating capillary blood flow. UNIFUZOL® exhibits cardioprotective, anti-ischemic, mild diuretic, and antiplatelet effects.
It improves pain-free walking distance and maximum walking distance in patients with intermittent claudication.
Active Pharmaceutical Substance: Arginine sodium succinate.
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
192102, Russia, Saint Petersburg,
Salova St., 72, Bldg. 2, Lit. A.
Pharmacovigilance group
of the Medical Department.